SCHEMBL4582030

SCHEMBL4582030

[CH2]c1cccc(-c2cnc(N3CCNCC3)nc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.48
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 1/20 0.47
HTR7 P34969 5/20 0.45
HTR1A P08908 4/20 0.45
TNF P01375 1/20 0.43
HTR1D P28221 1/20 0.42
HTR1B P28222 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
HTR2B P41595 1/20 0.42
HTR6 P50406 1/20 0.42
FEN1 P39748 1/20 0.41
INPPL1 O15357 1/20 0.41
BMPR1A P36894 1/20 0.41
ACVR1B P36896 1/20 0.41
ACVRL1 P37023 1/20 0.41
ACVR1 Q04771 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC2 Q92769 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4582036 0.82 ADRB1 (0.54) TAAR1ALDH1A1KDM4EHTR7HTR1A
SCHEMBL4582832 0.81 TAAR1 (0.49) TAAR1ALDH1A1KDM4EFEN1INPPL1
SCHEMBL9400977 0.81 TAAR1 (0.64) TAAR1ALDH1A1KDM4EHTR7HTR1A
SCHEMBL15000493 0.79 TAAR1 (0.55) TAAR1ALDH1A1KDM4ETNF
SCHEMBL9401046 0.79 ALDH1A1 (0.57) TAAR1ALDH1A1KDM4EHTR1DHTR2C
SCHEMBL25255051 0.77 ALDH1A1 (0.59) TAAR1ALDH1A1KDM4EHPGDMAPT
Hydrochloric Acid SCHEMBL20293586 0.76 MAP3K11 (0.50) ALDH1A1KDM4E
SCHEMBL6783114 0.76 ALDH1A1 (0.54) TAAR1ALDH1A1KDM4EINPPL1BMPR1A
SCHEMBL6782999 0.75 ADRB1 (0.53) TAAR1ALDH1A1KDM4EFEN1INPPL1
SCHEMBL9400849 0.72 HTR3A (0.54) TAAR1ALDH1A1KDM4EHTR7HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362017-B2 N-[5-chloro-2-(methyloxy)phenyl]-2-{[3-(1H-tetrazol-1-yl)phenyl]oxy}acetamide; antiproliferative agents; protein kinase inhibitors; drug screening EXELIXIS, INC. (US) 2013-01-29 US disclosed
CN-102498091-A Glycine compound ASTELLAS PHARMA INC 2012-06-13 CN disclosed
US-20080096892-A1 C-Kit Modulators And Methods Of Use EXELIXIS, INC. (US) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096892-A1 C-Kit Modulators And Methods Of Use KIT, PRKCH, PRKCB TAAR1 4080/4885ALDH1A1 2190/4885KDM4E 1020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.